Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Nurse

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Trends in Biotechnology|July 18, 2024
Applications and evolution of 3D cancer-immune cell modelsIleana L Co, Aleksandra Fomina, Michelle Nurse, et al.
Trends in Biotechnology|April 7, 2026
Engineering in vitro models to target tumour recurrenceNila C Wu, Ruonan Cao, Michelle Nurse, et al.
Scientific Reports|July 3, 2025
Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypesNatalie Landon-Brace, Simon Latour, Brendan T Innes, et al.
Biomaterials|October 12, 2024
The use of a multi-metric readout screen to identify EHMT2/G9a-inhibition as a modulator of cancer-associated fibroblast activation stateNila C Wu, Rene Quevedo, Michelle Nurse, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Trends in Biotechnology|July 18, 2024
Applications and evolution of 3D cancer-immune cell modelsIleana L Co, Aleksandra Fomina, Michelle Nurse, et al.
Trends in Biotechnology|April 7, 2026
Engineering in vitro models to target tumour recurrenceNila C Wu, Ruonan Cao, Michelle Nurse, et al.
Scientific Reports|July 3, 2025
Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypesNatalie Landon-Brace, Simon Latour, Brendan T Innes, et al.
Biomaterials|October 12, 2024
The use of a multi-metric readout screen to identify EHMT2/G9a-inhibition as a modulator of cancer-associated fibroblast activation stateNila C Wu, Rene Quevedo, Michelle Nurse, et al.
Pageof 1